Inoculation Site from a Cutaneous Melanoma Patient Treated with an Allogeneic Therapeutic Vaccine: A Case Report

We have developed a therapeutic vaccine consisting of a mixture of lethally-irradiated allogeneic cutaneous melanoma cell lines with BCG and GM-CSF as adjuvants. The CSF-470 vaccine is currently being assayed in a Phase II–III trial against medium-dose IFN-α2b. All vaccinated patients immunized intr...

Descripción completa

Detalles Bibliográficos
Autores principales: Aris, Mariana, Bravo, Alicia Inés, Barrio, María Marcela, Mordoh, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378302/
https://www.ncbi.nlm.nih.gov/pubmed/25870600
http://dx.doi.org/10.3389/fimmu.2015.00144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378302/
https://www.ncbi.nlm.nih.gov/pubmed/25870600
http://dx.doi.org/10.3389/fimmu.2015.00144

Ejemplares similares